ayvakyt
blueprint medicines (netherlands) b.v. - avapritinib - tumorile stromale gastro-intestinale - alte medicamente antineoplazice, inhibitori de proteinkinază - ayvakyt is indicated as monotherapy for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumours (gist) harbouring the platelet-derived growth factor receptor alpha (pdgfra) d842v mutation.
ayvakyt 100 mg
blueprint medicines (netherlands) b.v. - olanda - avapritinibum - compr. film. - 100mg - inhibitori de protein-kinaza alti inhibitori de protein kinaza
ayvakyt 200 mg
blueprint medicines (netherlands) b.v. - olanda - avapritinibum - compr. film. - 200mg - inhibitori de protein-kinaza alti inhibitori de protein kinaza
ayvakyt 25 mg
blueprint medicines (netherlands) b.v. - olanda - avapritinibum - compr. film. - 25mg - inhibitori de protein-kinaza alti inhibitori de protein kinaza
ayvakyt 300 mg
blueprint medicines (netherlands) b.v. - olanda - avapritinibum - compr. film. - 300mg - inhibitori de protein-kinaza alti inhibitori de protein kinaza
ayvakyt 50 mg
blueprint medicines (netherlands) b.v. - olanda - avapritinibum - compr. film. - 50mg - inhibitori de protein-kinaza alti inhibitori de protein kinaza